Feb. 20, 2025 -- The FDA has approved a new fast-acting insulin biosimilar to help manage blood sugar in people with diabetes, including children and adults. The product, called Merilog ...

The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

The Biosimilars Council recently commented on a report released by Matrix Global Advisors, titled U.S. Biosimilars Market: Addressing Barriers to Success in the Second Decade, which recommends ...